tiprankstipranks
Trending News
More News >
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Income Statement

Compare
505 Followers

Acumen Pharmaceuticals Income Statement

Last quarter (Q3 2025), Acumen Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acumen Pharmaceuticals's net income was $-26.45M. See Acumen Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.44M
Gross Profit
$ 0.00$ 0.00$ -169.00K$ -12.30M$ -6.56M
Operating Expenses
$ 114.02M$ 61.14M$ 45.24M$ 7.28M$ 1.35M
Depreciation and Amortization
$ 178.00K$ 184.00K$ 169.00K$ 4.00K$ 0.00
EBITDA
$ -98.08M$ -51.61M$ -42.69M$ -19.58M$ -7.91M
Operating Income
$ -114.02M$ -61.14M$ -45.24M$ -19.58M$ -7.91M
Other Income/Expenses
$ 11.69M$ 8.77M$ 2.38M$ -81.02M$ 587.00K
Pretax Income
$ -102.33M$ -52.37M$ -42.86M$ -100.61M$ -7.33M
Net Income
$ -102.33M$ -52.37M$ -42.86M$ -100.61M$ -7.33M
Per Share Metrics
Basic EPS
$ -1.71$ -1.08$ -1.06$ -2.63$ -0.26
Diluted EPS
$ -1.71$ -1.08$ -1.06$ -2.63$ -0.26
Weighted Average Shares Outstanding
60.01M 48.49M 40.60M 38.27M 28.65M
Weighted Average Shares Outstanding (Diluted)
60.01M 48.61M 40.60M 38.27M 28.65M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History